Additionally, cardiac arrest or sudden cardiac death occurred in 11%, reflecting the substantial arrhythmogenic risk associated with SCN5A-related DCM, though this may also be influenced by advanced heart failure irrespective of genotype [10]. Here, SCN5A is linked to heart failure.